Multiple myeloma clinical trial closes early

User rating: 4 / 5 after 4 vote(s)

Mayo Clinic Cancer Center announced today that a multiple myeloma clinical trial has shown a significant improvement in survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone.